Magnasense AB (STO:MAGNA)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.1320
0.00 (0.00%)
At close: Apr 22, 2025
-75.00%
Market Cap 11.00M
Revenue (ttm) n/a
Net Income (ttm) -49.63M
Shares Out 84.76M
EPS (ttm) -1.22
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 13,155,270
Average Volume 1,626,260
Open 0.1402
Previous Close n/a
Day's Range 0.1300 - 0.2105
52-Week Range 0.1022 - 1.4990
Beta 2.75
RSI 40.57
Earnings Date Mar 31, 2025

About Magnasense AB

Magnasense AB develops and commercializes diagnostic tests for monitoring and optimizing the dosage of biological drugs in Sweden and internationally. The company develops a home testing platform for oral health, therapeutic drug monitoring, and infectious diseases. Its product line includes the Veritope technology with intact natalizumab in multiple sclerosis; and the MagniaReader which is utilized in research and veterinary applications. The company was formerly known as AegirBio AB (publ) and changed its name to Magnasense AB in July 2024. M... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2019
Employees 14
Stock Exchange Nasdaq Stockholm
Ticker Symbol MAGNA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.